Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical ... and central nervous system and metabolic disease. It employs more than 5,000 people globally.

Mitsubishi Tanabe Pharma, also known as Tanabe Pharma, is the pharmaceutical division of Mitsubishi Chemical Group ... central nervous system disorders; and diabetes and metabolic disease.

TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to U.S. investment fund Bain Capital for approximately ...